The IGF/IGFBP system in relation to macroscopic bone architecture in pediatric renal transplant patients
- PMID: 20033221
- DOI: 10.1007/s00467-009-1405-5
The IGF/IGFBP system in relation to macroscopic bone architecture in pediatric renal transplant patients
Abstract
The post-transplant bone disease of the peripheral skeleton in pediatric renal transplant recipients is characterized by an inadequately thin bone cortex in relation to muscular force. A major hormonal modulator of periosteal growth is the insulin-like growth factor (IGF)/IGF binding protein (IGFBP) system. We therefore hypothesized that the reduced cortical thickness in these patients may be due to functional IGF deficiency. To test this hypothesis, we investigated 55 patients (mean estimated glomerular filtration rate 86.3 +/- 30.0 ml/min/1.73 m(2)) in a cross-sectional study. Parameters of macroscopic bone architecture and forearm muscle size were analyzed by peripheral quantitative computed tomography (pQCT), and serum IGF/IGFBP system components were measured by specific radioimmunoassays. The mean (+/- standard deviation) standardized serum IGF-I (0.20 +/- 1.16 score) level was normal, while the mean IGF-II (1.16 +/- 0.11 score) level was significantly elevated. Serum IGFBP-1 and IGFBP-2 levels were not altered, whereas the IGFBP-3 (1.34 +/- 0.15 score) level was significantly increased. The serum IGFBP-4 level was slightly elevated (by 11%), the IGFBP-6 level was markedly (2.3-fold) elevated, while the IGFBP-5 level was comparable to that of the control. The respective age-adjusted cortical thickness at both the proximal (r = 0.407, P < 0.005) and distal (r = 0.383, P < 0.01) forearm was positively correlated with the standardized serum IGF-I level. In conclusion, the serum IGF/IGFBP system in pediatric renal transplant recipients is characterized by an increase in the levels of the inhibitory IGFBPs, IGFBP-3, -4 and -6, resulting in a functional IGF deficiency. The positive correlation of IGF-I with cortical thickness underlines the importance of this hormonal system in the modeling of bone, particularly periosteal growth.
Similar articles
-
Insulin-like growth factor system components in hyperparathyroidism and renal osteodystrophy.Kidney Int. 2000 Feb;57(2):423-36. doi: 10.1046/j.1523-1755.2000.00862.x. Kidney Int. 2000. PMID: 10652019
-
Serum insulin-like growth factors (IGFs) and IGF binding proteins 1, 2, and 3 in children with chronic renal failure: relationship to height and glomerular filtration rate. The European Study Group for Nutritional Treatment of Chronic Renal Failure in Childhood.J Clin Endocrinol Metab. 1995 Sep;80(9):2684-91. doi: 10.1210/jcem.80.9.7545697. J Clin Endocrinol Metab. 1995. PMID: 7545697
-
Serum insulin-like growth factors and their binding proteins in children with end-stage renal disease.Pediatr Nephrol. 1996 Jun;10(3):269-74. doi: 10.1007/BF00866755. Pediatr Nephrol. 1996. PMID: 8792388 Clinical Trial.
-
Derangements of the somatotropic hormone axis in chronic renal failure.Kidney Int Suppl. 1997 Mar;58:S106-13. Kidney Int Suppl. 1997. PMID: 9067957 Review.
-
Insulin-like growth factors (IGF) and IGF binding proteins in children with chronic renal failure.Prog Growth Factor Res. 1995;6(2-4):481-91. doi: 10.1016/0955-2235(96)00003-8. Prog Growth Factor Res. 1995. PMID: 8817693 Review.
Cited by
-
Growth hormone improves growth in pediatric renal transplant recipients--a systemic review and meta-analysis of randomized controlled trials.Pediatr Nephrol. 2013 Jan;28(1):129-33. doi: 10.1007/s00467-012-2208-7. Epub 2012 Jun 4. Pediatr Nephrol. 2013. PMID: 22660958
-
Bone density and cortical structure after pediatric renal transplantation.J Am Soc Nephrol. 2012 Apr;23(4):715-26. doi: 10.1681/ASN.2011050480. Epub 2012 Jan 26. J Am Soc Nephrol. 2012. PMID: 22282589 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous